A successful treatment by hepatic arterial infusion therapy for advanced, unresectable biliary tract cancer
- PMID: 21160995
- PMCID: PMC2999280
- DOI: 10.4254/wjh.v2.i5.192
A successful treatment by hepatic arterial infusion therapy for advanced, unresectable biliary tract cancer
Abstract
Biliary tract cancers (BTC) are relatively rare tumors, and the prognosis is extremely poor. There has been no standard chemotherapy for advanced BTC. However, recently, gemcitabine (GEM) have been used against BTC as the most active agent, and promising response rates and overall survival times with tolerable drug toxicities have been observed. In this article, two cases of advanced intrahepatic cholangiocarcinoma and unresectable metastatic gallbladder (GB) cancer are reported. They were treated with hepatic arterial infusion (HAI) chemotherapy using a combination of GEM and cisplatin, along with the systemic administration of GEM. As a consequence, multiple liver tumors, the GB cancer and metastatic lymph nodes regressed without severe drug toxicities, and favorable results (the overall survival times were 16 and 14 mo, respectively) were achieved. In conclusion, HAI therapy using GEM combined with cisplatin may be a useful and well-tolerated option for advanced BTC, especially in cases where multiple liver metastases are detected.
Keywords: Cisplatin; Gallbladder cancer; Gemcitabine; Hepatic arterial infusion; Intrahepatic cholangiocarcinoma.
Figures








Similar articles
-
Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report.Surg Case Rep. 2017 Nov 21;3(1):116. doi: 10.1186/s40792-017-0395-y. Surg Case Rep. 2017. PMID: 29164423 Free PMC article.
-
Conversion surgery for initially unresectable advanced biliary tract cancer treated with gemcitabine plus cisplatin combination chemotherapy: a case report and literature review.Int Cancer Conf J. 2022 Mar 29;11(3):188-195. doi: 10.1007/s13691-022-00545-y. eCollection 2022 Jul. Int Cancer Conf J. 2022. PMID: 35669899 Free PMC article.
-
Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case.Surg Case Rep. 2019 Jun 24;5(1):103. doi: 10.1186/s40792-019-0656-z. Surg Case Rep. 2019. PMID: 31236705 Free PMC article.
-
Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review.Cancer Res Treat. 2015 Jul;47(3):343-61. doi: 10.4143/crt.2014.308. Epub 2015 May 18. Cancer Res Treat. 2015. PMID: 25989801 Free PMC article. Review.
-
New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma.Cancers (Basel). 2023 Aug 6;15(15):3993. doi: 10.3390/cancers15153993. Cancers (Basel). 2023. PMID: 37568808 Free PMC article. Review.
Cited by
-
Intra-arterial chemotherapy improved survival of stage 2-3 gallbladder cancer after curative resection.Onco Targets Ther. 2018 May 22;11:2975-2979. doi: 10.2147/OTT.S166246. eCollection 2018. Onco Targets Ther. 2018. PMID: 29872309 Free PMC article.
-
Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.Oncol Rep. 2016 May;35(5):2576-82. doi: 10.3892/or.2016.4681. Epub 2016 Mar 16. Oncol Rep. 2016. PMID: 26985715 Free PMC article.
-
Different interventional time of hepatic arterial infusion with PD-1 inhibitor for advanced biliary tract cancer: a multicenter retrospective study.Am J Cancer Res. 2022 Jul 15;12(7):3455-3463. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968352 Free PMC article.
-
Intra-arterial chemotherapy with doxorubicin and cisplatin is effective for advanced hepatocellular cell carcinoma.ScientificWorldJournal. 2014;2014:160138. doi: 10.1155/2014/160138. Epub 2014 May 22. ScientificWorldJournal. 2014. PMID: 24967421 Free PMC article.
References
-
- Knox JJ, Hedley D, Oza A, Siu LL, Pond GR, Moore MJ. Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. Ann Oncol. 2004;15:770–774. - PubMed
-
- Alberts SR, Al-Khatib H, Mahoney MR, Burgart L, Cera PJ, Flynn PJ, Finch TR, Levitt R, Windschitl HE, Knost JA, et al. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial. Cancer. 2005;103:111–118. - PubMed
-
- Park JS, Oh SY, Kim SH, Kwon HC, Kim JS, J-Kim H, Kim YH. Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study. Jpn J Clin Oncol. 2005;35:68–73. - PubMed
-
- Yonemoto N, Furuse J, Okusaka T, Yamao K, Funakoshi A, Ohkawa S, Boku N, Tanaka K, Nagase M, Saisho H, et al. A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol. 2007;37:843–851. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials